Previous studies showed that stimulation of the PI3K/AKT signaling pathway is involved in tumor proliferation, angiogenesis, invasion and metastasis, and also has a significant impact on tumor resistance and chemoradiotherapy antagonism [33]. The gene discussed is AKT1; the disease is neoplasm.